The EOC the multisite hospital of Ticino is present with its institutions on the entire cantonal territory with a total of 1,000 beds. The organization makes it possible to effectively combine local approach and overall vision, guaranteeing the population a comprehensive and proximity hospital offer, regardless of where services are required.


Thanks to the commitment and expertise of its more than 6,500 employees and their focus on human relationships, the EOC ensures quality health care by caring for more than 41,000 patients a year and providing more than 600,000 ambulatory consultations.


To complete the team at the Oncological Institute of Southern Switzerland (IOSI) Bellinzona, Clinical Research Unit and Phase 1 Program, we are looking for a/an


**Medico Capoclinica / Senior Staff Physician (80-100%)**
The Oncology Institute of Southern Switzerland is one of the largest clinical research centers in Switzerland. Our three main areas of clinical research comprise new drug development, lymphoproliferative diseases and prostate cancer. Other important areas of development in clinical research include gynecological, breast, lung, skin and gastrointestinal cancer.


The IOSI has a dedicated Phase 1 Unit where early phase clinical trials, including first-in-human, are conducted. We have an excellent history of collaborating with both non-for-profit academic organizations and the pharmaceutical industry. Of particular relevance are our collaborations with the Institute of Oncology Research (IOR), the Institute of Biochemical Research (IRB) and the Swiss Cancer Institute (SCI, ex SAKK). We have a central role in the Faculty of Biomedical Sciences of the Università della Svizzera Italiana (USI).


To further expand the clinical and research activities of our Phase I Unit, we are seeking a highly motivated Senior Staff Physician with expertise in drug development and early-phase clinical trials in oncology.


The successful candidate will join a dynamic, multidisciplinary, and internationally connected environment, with excellent opportunities for professional and academic growth, career development, and active participation in innovative translational and clinical research programs. Clinical activities within a selected disease group can also be considered, aligned with the candidate’s areas of expertise.


**Essential Requirements**

- Medical degree and completed specialist training in Medical Oncology.
- For candidates holding foreign qualifications, recognition by the Swiss Federal Commission for Medical Professions (MEBEKO) is mandatory . The qualification must be equivalent to the Swiss standard; however, recognition may be obtained after acceptance of the position. Registration in MedReg is also required, including proof of proficiency in one or more Swiss official languages (Italian, German, or French).
- Proficiency in both Italian and English.
- Previous experience in early-phase clinical trials in oncology; at least 2–3 years of experience in a Phase I Unit is highly desirable.
- Strong interest in and commitment to contributing to the clinical and research activities of the Phase I Unit at the Oncology Institute of Southern Switzerland (IOSI).
- Enthusiasm for actively supporting the growth and development of our Phase 1 Unit
- Availability to support and supervise residents and clinical fellows as part of the Institute’s educational and training activities
- Excellent interpersonal and communication skills, with the ability to work effectively in a multidisciplinary and research-oriented environment.
- Demonstrated initiative, flexibility, organizational skills, and a collaborative approach to interdisciplinary and translational research activities.

**Candidates who do not yet hold a specialist title in Medical Oncology are not eligible for this position.**
**Timeline**
The entry date is expected from September 2026, but we are flexible and an individual start date can be also considered.


For more information you can write to the e-mail address ilaria.colombo@eoc.ch, ricerca.IOSI@eoc.ch. No paper applications will be accepted.